The Chinese Journal of Alzheimer’s Disease and Related Disorders, the first journal dedicated to Alzheimer’s disease and related neurodegenerative diseases in China, was founded by Chinese Association for Alzheimer’s disease (CAAD)(CN 10-1536/R, ISSN 2096—5516) in early 2018.

This bimonthly publication is a peer-reviewed professional academic journal in the field of Alzheimer’s disease and related disorders which covers a broad spectrum of research, including basic science research, clinical studies, and drug discovery in translational medicine relating to the study of Alzheimer’s disease and other neurodegenerative diseases. The Chinese Journal of Alzheimer’s Disease and Related Disorders is establishing itself as one of the most influential and relied upon journals in the field of neurodegenerative diseases which serves as one of the premier intellectual forums in the national and international communities, including professional neuroscientists, clinical physicians and practitioners, drug developers, medical and health care workers, students, caregivers, and others in different institutions.

The aims of this journal are to publish new exciting research findings and clinical reports in the frontiers of research in Alzheimer’s disease and related disorders, promote academic exchanges, advance transformation of achievements, popularize preventative and ameliorative interventions, and further promote development in the prevention and treatment of Alzheimer’s disease and other neurodegenerative disorders.